How do I get the best results from Semaglutide GLP-1
3533 participants with type 2 diabetes and chronic kidney disease were randomly assigned to receive weekly subcutaneous semaglutide (1.0 mg) or placebo
Consult with your doctor to discuss whether retatrutide or semaglutide is right for you
Is it the same as the brand name version?", CBC News website , archived from the original on 20 May 2026 "Australian Product Information: Ozempic (semaglutide) solution for injection" (PDF), Therapeutic Goods Administration website , 30 October 2020, archived from the original (PDF) on 8 June 2025 "Assessment report: Ozempic" (PDF), European Medicines Agency website , 11 November 2021, archived from the original (PDF) on 6 February 2025 1 2 "Novo Nordisk CEO flags 1.5 million US users of compounded GLP-1 drugs"
Tirzepatide, at both doses, led to significant reductions in bodyweight compared to placebo at week 72
This weight loss also provides the patient with increased energy levels